Jun Hirai

Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae

Hazuki Nakai, Mao Hagihara, Hideo Kato et al. · Journal of Infection and Chemotherapy · 2016 · 74 citations

Antimicrobial Susceptibility, Microbial Disease, Antibiotics +11

Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen

Hideo Kato, Mao Hagihara, Jun Hirai et al. · Drugs in R&D · 2017 · 53 citations · Full text

Clostridium butyricum-induced ω-3 fatty acid 18-HEPE elicits anti-influenza virus pneumonia effects through interferon-λ upregulation

Mao Hagihara, Makoto Yamashita, Tadashi Ariyoshi et al. · Cell Reports · 2022 · 50 citations · Full text

Microbial Pathogens, Lung Inflammation, Gut-lung Axis Mechanism +16

Rituximab Restores IFN-γ-STAT1 Function and Ameliorates Disseminated Mycobacterium avium Infection in a Patient with Anti-Interferon-γ Autoantibody

Yusuke Koizumi, Takuro Sakagami, Naoya Nishiyama et al. · Journal of Clinical Immunology · 2017 · 47 citations

Pulmonary Tuberculosis, Autoimmune Disease, Immunodeficiencies +7

Retrospective study of teicoplanin loading regimen that rapidly achieves target 15–30 μg/mL serum trough concentration

Hideo Kato, Yukihiro Hamada, Mao Hagihara et al. · Journal of Infection and Chemotherapy · 2016 · 29 citations

Retrospective Study, Therapeutic Drug Monitoring, Medicine +6